Assisted Reproductive Technology Market Industry Analysis, Size and Segment To 2022

The global assisted reproductive technology market is expected to reach USD 29.3 billion by 2022, according to a new report by Grand View Research Inc. Growing prevalence of stress and increase in the pollution levels coupled with the changing lifestyle habits including smoking and drinking are expected to drive the assisted reproductive technology market over the forecast period.
Growing incidence rate of male and female infertility due to low sperm count, poor sperm movement, blocked sperm ducts, and fallopian tubes blockage coupled with problems in uterus or cervix, respectively is expected to significantly contribute towards market growth.
Medical tourism is instrumental in facilitating growing demand of assisted human reproductive technology. Although, these technologies are widely used in the developed economies of the U.S. and Canada, entailed high costs render these services unavailable to every patient. Nations are regulated by stringent laws and govern the transactions between surrogates, egg donors, and those who are willing to avail these services.
Countries such as Czech Republic, Israel, South Africa, and Spain offer good fertility options. India and Mexico were among the most technologically and economically viable fertility choices for foreign couples. Success rates as good as other western nations and with less than half the cost, are few factors spearheading regional growth.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/assisted-reproductive-technology-market

U.S. assisted reproductive technology market, by procedure, 2012-2022, (USD Million)

 

 Further Key findings from the study suggest:

• Zinc was the highest consumed mineral and accounted for over 45% of the global consumption in 2012. The high consumption can be associated with multiple advantages offer by zinc such as antioxidant, tissue repair, wound healing and cofactor for enzymes. It is also expected to witness fastest growth over the next six years growing at a CAGR of nearly 7% from 2013 to 2020. 
• The other commonly used trace minerals include Iron, Manganese, Copper, Selenium and Cobalt. Iron and Manganese were the second and third largest segments in 2012 and together accounted for over USD 110.0 million of revenue. 
• North America was the largest regional market for organic trace minerals and accounted for close to 38% of the revenue in 2012. It is expected to be the dominant regional market by the end of the forecast period in spite of losing share to fastest growing markets such as Asia Pacific and Brazil. 
• Asia Pacific is expected to be the fastest growing region in terms of organic trace mineral consumption because of the increased consumption of animal as a source of protein coupled with increasing awareness regarding benefits of these minerals in controlling and prevention of diseases. The region is expected to grow at a CAGR of over 7% from 2013 to 2020. 
• Royal DSM NV was the largest company in the market and further strengthened market presence following its acquisition of Brazil based organic trace mineral company, Tortuga. The other key companies in the market include Tanke Biosciences Corporation, Ridley Inc, Zinpro Corporation, Archer Daniels Midland Company, Cargill and Kemin Industries among others. 

Browse All Reports of this category @ http://www.grandviewresearch.com/industry/biotechnology